Print

Nanosphere, Inc. to Present at the Jefferies and Co. 2013 Global Healthcare Conference  
6/4/2013 10:38:00 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NORTHBROOK, IL--(Marketwired - June 03, 2013) - Nanosphere, Inc., (NASDAQ: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that an overview of the company's business and commercial strategy will be given by Nanosphere's President and Chief Executive Officer Michael McGarrity at the Jefferies 2013 Global Healthcare Conference, being held at the Grand Hyatt Hotel in New York City. The Company presentation is on Wednesday, June 5 at 2:00pm Eastern Time.

A live webcast of Nanosphere's presentation will be available at www.nanosphere.us.

About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for multiplexed infectious disease, genetic, and ultra-sensitive protein testing. This easy-to-use platform offers laboratories a convenient, simple, and cost-effective solution for highly sensitive nucleic acid and protein testing. Nanosphere is based in Northbrook, IL.

For additional information regarding Nanosphere's infectious disease products, please contact Nanosphere at IDtesting@nanosphere.us or visit www.nanosphere.us.

Except for historical information, the matters discussed in this press release are "forward-looking statements" and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere's ability to develop commercially viable products; (ii) Nanosphere's ability to achieve profitability; (iii) Nanosphere's ability to produce and market its products; (iv) Nanosphere's ability to obtain regulatory approval of its products; (v) Nanosphere's ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere's ability to obtain additional financing to support its operations. Additional risks are discussed in the Company's current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.


Contact:
Nanosphere, Inc.
Roger Moody
847-400-9021
Chief Financial Officer
rmoody@nanosphere.us

LifeSci Advisors, LLC
Michael Rice
646-597-6979
Founding Partner
mrice@lifesciadvisors.com



Help employers find you! Check out all the jobs and post your resume.

//-->